Patients in daily clinical practice are more complex and often have CAD, arterial hypertension, heart failure, diabetes, and CKD, so elevated Gal-3 levels may have an even greater significance in this group of patients for the prediction of significant coronary disease as well as adverse cardiovascular events. Here, LGALS3 is linked to heart failure.